Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2006 | 03-2006 | 12-2005 | 09-2005 | 06-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,533 | 22,393 | 46,889 | 37,352 | 29,020 |
| Marketable Securities | 6,417 | 63,787 | 80,327 | 98,430 | 69,434 |
| Receivables | 74,135 | 56,607 | 49,007 | 46,786 | 46,275 |
| Inventories | 92,981 | 77,153 | 67,476 | 69,014 | 69,206 |
| Income taxes - deferred | 12,793 | 11,728 | 10,842 | N/A | N/A |
| TOTAL | $226,463 | $242,826 | $265,952 | $269,659 | $225,172 |
| Non-Current Assets | |||||
| PPE Net | 35,791 | 29,079 | 27,451 | 27,511 | 27,691 |
| Investments And Advances | 9,693 | 11,683 | 16,168 | 23,251 | 49,394 |
| Intangibles | 287,868 | 202,144 | 132,933 | 135,920 | 137,556 |
| Other Non-Current Assets | 6,404 | 5,899 | 5,928 | 9,540 | 11,873 |
| TOTAL | $339,756 | $248,805 | $182,480 | $196,222 | $226,514 |
| Total Assets | $566,219 | $491,631 | $448,432 | $465,881 | $451,686 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 16,192 | 10,054 | 8,978 | 9,118 | 12,788 |
| Accrued Expenses | 25,147 | 21,446 | 21,506 | 8,449 | 9,313 |
| TOTAL | $113,619 | $53,768 | $31,287 | $33,536 | $32,263 |
| Non-Current Liabilities | |||||
| Long Term Debt | 118,112 | 118,169 | N/A | 118,468 | 119,159 |
| Deferred Revenues | 8,280 | 5,792 | 88 | N/A | N/A |
| Other Non-Current Liabilities | 7,537 | 6,700 | 124,807 | 6,275 | 5,304 |
| TOTAL | $140,554 | $128,815 | $127,327 | $124,743 | $124,727 |
| Total Liabilities | $254,173 | $182,583 | $158,614 | $158,279 | $156,990 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,724 | 57,151 | 56,870 | 56,101 | 58,986 |
| Common Shares | 311 | 310 | 298 | 296 | 295 |
| Retained earnings | 53,611 | 45,634 | 36,929 | 26,314 | 15,833 |
| Other shareholders' equity | 1,645 | -2,725 | -4,588 | -3,580 | -3,348 |
| TOTAL | $312,046 | $309,048 | $289,818 | $307,602 | $294,696 |
| Total Liabilities And Equity | $566,219 | $491,631 | $448,432 | $465,881 | $451,686 |